title: Antibodies to commercially available interferon-beta molecules in multiple sclerosis patients treated with natural interferon-beta.
authors.affiliation: Neurology Service, and Research Unit of Carlos Haya Hospital, Malaga, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Mayorga
authors.forename: G
authors.initials: G
authors.lastname: Luque
authors.forename: F
authors.initials: F
authors.lastname: Romero
authors.forename: R
authors.initials: R
authors.lastname: Guerrero
authors.forename: M
authors.initials: M
authors.lastname: Blanca
authors.forename: O
authors.initials: O
authors.lastname: Fernandez
mesh_terms: D000906:Antibodies / Q000097:blood / Q000276:immunology*; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000276:immunology* / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy / Q000276:immunology*
chemical_list: D000906:Antibodies; D016899:Interferon-beta